Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Constipation is one of the most common gastrointestinal side effects of GLP-1 receptor agonists, occurring in approximately 25% of patients during the first month of therapy. While this effect typically diminishes as your body adapts, knowing which interventions work—and which to avoid—can make the adjustment period much more comfortable. PlexusDx provides evidence-based guidance to help you manage this challenge while continuing your personalized weight loss therapy.
Why GLP-1 Medications Cause Constipation
GLP-1 receptor agonists like semaglutide work by slowing gastric emptying—the rate at which food moves from your stomach into your small intestine. This mechanism helps reduce hunger and increase fullness, which are key to weight loss success. However, this same slowdown in digestive transit can reduce bowel movement frequency and lead to harder, less frequent stools.
The constipation effect is dose-dependent, meaning it often improves as your body becomes tolerant over weeks to months. Most patients experience peak symptoms during the first 2–4 weeks of treatment or after a dose increase. Understanding this timeline helps you distinguish between expected adaptation and a side effect requiring intervention.
Individual responses vary based on genetics, baseline diet, hydration, and physical activity. PlexusDx's Precision Peptide Genetic Test identifies genetic variants in pathways like GLP1R and MC4R that may influence how your body responds to GLP-1 therapy, helping predict which patients are at higher risk for digestive side effects.
Dietary and Lifestyle Strategies for GLP-1 Constipation
Increasing soluble fiber intake is often the first-line approach, but it must be done gradually. Soluble fiber from sources like oats, psyllium husk, ground flaxseed, and legumes absorbs water and softens stool. Start with small amounts—adding fiber too quickly while on a GLP-1 can cause bloating and gas. Aim for 25–35 grams of total fiber daily, spread throughout meals, rather than consuming it all at once.
Hydration plays a critical role in preventing and relieving constipation. GLP-1 medications can suppress thirst signals, meaning you may not feel as thirsty as you actually are. Drink at least 8–10 glasses (64–80 ounces) of water daily, more if you exercise or live in a hot climate. Herbal teas and broths count toward your fluid intake and can be easier on a reduced appetite.
Physical activity accelerates bowel motility and promotes regular bowel movements. Even light movement—a 15–20 minute walk after meals—can help. Exercise also improves gastric emptying rate over time, which may reduce the intensity of GLP-1 side effects. Consistency matters more than intensity; daily gentle movement often outperforms occasional intense workouts for digestive health.
Over-the-Counter and Natural Remedies
Osmotic laxatives like polyethylene glycol (PEG 3350, brand name GoLYTELY or Miralax) are often recommended as first-line medication support. These work by drawing water into the intestinal lumen, softening stool without increasing intestinal contractions. They are generally well-tolerated and safe for long-term use. Typical dosing is 17 grams (one tablespoon) once or twice daily, mixed with 8 ounces of liquid.
Stool softeners containing docusate sodium are another gentle option, particularly for those with hard, painful stools. These medications reduce surface tension in stool, allowing water penetration. However, stool softeners work best when combined with adequate hydration and fiber intake. Avoid stimulant laxatives (such as bisacodyl or senna) as first-line treatments, as they can cause cramping and may create dependency with prolonged use.
Natural options include magnesium supplementation (200–400 mg daily), which has mild osmotic properties and is well-tolerated. Prune juice, kiwi fruit, and chia seeds have mild evidence supporting their use. Peppermint tea may help reduce bloating if constipation is accompanied by gas. Always consult your PlexusDx healthcare provider before starting any new supplement, as some may interact with your GLP-1 therapy or other medications.
When to Seek Medical Guidance and Adjust Your GLP-1 Plan
Contact your healthcare provider if constipation persists beyond 2–3 weeks despite dietary and over-the-counter interventions, if you experience severe abdominal pain, or if constipation is significantly affecting your quality of life. These symptoms may warrant a dose pause, slower titration schedule, or evaluation for other underlying conditions. Your PlexusDx care team can review whether your current dose and medication formulation—whether Semaglutide Injection, Oral Semaglutide, or another compound—remains the best choice for your body.
Some patients find relief by spacing out dose increases more gradually or by temporarily holding at a lower dose while their digestive system adapts. Others benefit from switching between injection and oral formulations, as absorption rates and peak levels differ. PlexusDx offers multiple GLP-1 options including Microdose GLP-1 Protocol, which may provide a gentler entry point for sensitive patients. Your Precision Peptide Genetic Test results can inform which formulation and dosing strategy aligns with your genetic profile for optimal tolerance and efficacy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is constipation on GLP-1 medications permanent?
No. Constipation typically peaks during the first 2–4 weeks and gradually improves as your body adjusts over 1–3 months. Most patients experience significant relief within 6–8 weeks without stopping treatment. If constipation persists beyond this period, speak with your PlexusDx provider about dose timing or formulation adjustments.
Can I use laxatives safely while taking semaglutide?
Yes, osmotic laxatives like polyethylene glycol (Miralax) and stool softeners are generally safe with semaglutide. Avoid stimulant laxatives as first-line treatment due to cramping risk. Always inform your PlexusDx healthcare team about any laxatives or supplements you use so they can ensure compatibility with your personalized therapy plan.
How does PlexusDx Semaglutide Injection help compared to other options?
PlexusDx Compounded Semaglutide Injection starts at $149/month and is formulated by licensed 503A compounding pharmacies for precision dosing. Your dose may need to go up, but your price won't—helping you adjust your therapy based on response without cost escalation. Many patients find injection formulations offer more reliable absorption than oral options, reducing digestive unpredictability.
Does the Precision Peptide Genetic Test predict constipation risk?
PlexusDx's Precision Peptide Genetic Test analyzes genetic variants in GLP1R, MC4R, FTO, and 11 other peptide pathways across 150+ insights. While constipation itself isn't directly predicted, your genetic profile reveals how your body's appetite and metabolic regulation systems respond, informing which GLP-1 formulation and dosing strategy may work best for your body.
What if dietary changes and over-the-counter remedies don't work?
Contact your PlexusDx healthcare provider. Options include adjusting your GLP-1 dose, slowing your titration schedule, or switching formulations—for example, from Semaglutide Injection to Oral Semaglutide or trying Microdose GLP-1 Protocol. Your care team will personalize your approach based on your tolerance and weight loss goals.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where to Inject Semaglutide: Guidelines for Safe and Effective Use
How Can I Lose Weight Without Ozempic? Exploring Natural and Effective Strategies